Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000187776 | SCV000241373 | uncertain significance | not provided | 2014-07-16 | criteria provided, single submitter | clinical testing | This variant is denoted p.Arg474His (CGT>CAT): c.1421 G>A in exon 3 of the KANSL1 gene (NM_001193466.1). The R474H variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, the R474H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Additionally, missense mutations in KANSL1 have not been reported in association with epilepsy. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. With the clinical and molecular information available at this time, the clinical significance of this variant is unknown. The variant is found in INFANT-EPI panel(s). |
| Invitae | RCV001294648 | SCV001483534 | uncertain significance | Koolen-de Vries syndrome | 2021-09-17 | criteria provided, single submitter | clinical testing |